|
|
|
|
|
|
|
Madrigal Pharmaceuticals Inc. (MDGL)
|
|
114.83 1.94 (1.72%)
|
12-11 12:53
|
|
Open:
|
113.43
|
Pre. Close:
|
112.89
|
|
High:
|
117.88
|
Low:
|
112.05
|
|
Volume:
|
68,325
|
Market Cap:
|
1768M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
114.858 - 115.576
|
115.576 - 116.082
|
|
Low:
|
105.902 - 106.764
|
106.764 - 107.371
|
|
Close:
|
111.713 - 113.025
|
113.025 - 113.951
|
|
|
|
Technical analysis (as of: 2018-12-11 11:53:30 AM)
|
|
Overall:
|
 
|
|
Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 206.47 One year: 256.50
|
|
Support:
|
Support1: 107.46 Support2: 89.41
|
|
Resistance:
|
Resistance1:
176.77 Resistance2: 219.61
|
|
Pivot:
|
115.90
|
|
Moving Averages:
|
MA(5): 114.85 MA(20): 123.88
MA(100): 203.85 MA(250): 176.15 
|
|
MACD:
|
MACD(12,26):
-17.13 Signal(12,26,9): -18.96
|
|
%K %D:
|
%K(14,3): 15.21 %D(3): 17.01
|
|
RSI:
|
RSI(14): 33.32
|
|
52-Week:
|
High: 325.98
Low: 77 Change(%): 39.2
|
|
Average Vol(K):
|
3-Month: 29152
10-Days 26706
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.MDGL has closed above bottom band by 24.8%. Bollinger Bands are 71.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to MDGL's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-11-26T05:00:00-05:00
Viking Therapeutics Won't Live Up To The Hype
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
